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After the development of fast imaging sequences, multiphasic dynamic imaging has been widely accepted as a standard hepatic magnetic resonance (MR) imaging protocol. Despite the limited spatial resolution, the inherently higher tissue contrast and more concentrated contrast agent give dynamic MR imaging superior capability to reveal the hypervascularity of hepatocellular carcinomas (HCCs) in comparison to computed tomography (CT) (1, 2).
Typical HCCs show hyperintensity in the arterial phase (AP) and hypointensity in the portal phase (PP) or delayed phase (DP) of dynamic MR imaging, which is similar to what has been reported with CT (3). Localized hypointensity with or without a peripherally enhancing capsular appearance at the area of arterial hypervascularity is referred to as a ''washout'' appearance, and it has generally been used to characterize hypervascular HCCs which are distinguishable from the hypervascular pseudolesions that show a rather isointense appearance in the late phases of dynamic MR imaging (4, 5) . However, based on our work over the past decade on the early diagnosis of HCC, we have found that the washout appearance is not always easy to see in the daily practice of hepatic MR imaging due to the size or the signal characteristics on precontrast images of each lesion. The purpose of our study was to investigate the practical value of PP and DP during dynamic MR imaging for the diagnosis of small hypervascular HCCs in the cirrhotic liver.
Material and Methods
Patients and MR imaging Approval for this retrospective study was obtained from our institutional review board, which waived the requirement for informed consent from the individual patients. We searched electronic medical records to identify patients who had HCC in a cirrhotic liver and who had undergone hepatic MR imaging between July 2000 and December 2002.
MR imaging was performed with a 1.5T unit (Vision; Siemens, Erlangen, Germany) with a phased-array multicoil. T2-weighted (T2W) images were obtained by multishot turbo spin-echo sequences (repetition time [TR]/effective echo time [TE] 3540Á4000/138 ms, echo train length 29) with chemically selective pre-pulse for fat suppression. In all cases, a double-echo chemical shift gradient-echo technique (TR 140 ms, TE 2.7 ms for opposedphase and 5.3 ms for in-phase, flip angle 908, matrix 128)256, field of view 240)320 mm 2 ) was performed for T1-weighted (T1W) imaging before and after an injection of 15 ml of gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany) with a 3 ml/s injection rate through the antecubital vein followed by saline flush. An 8Á10mm slice thickness with a 1.6Á2-mm intersection gap was used for 15 axial sections during a 19Á21-s acquisition time encompassing the entire liver during a single breath-holding period. Three-phase (AP, PP, and 5-min DP) contrast-enhanced dynamic imaging was performed. The delay time for AP and PP imaging was determined after the testbolus examination and before dynamic imaging, according to a previously described method (6) . For patients with difficulty in breath-holding, half-Fourier acquisition turbo spin-echo (TR/TE infinite/90 ms) was repeated for T2W imaging. All scans were sent to a picture archiving and communication system (PACS) for interpretation on PACS workstations.
An attending radiologist with 10 years of experience in hepatic MR imaging retrieved the images and conducted a preliminary review on the PACS monitor in conjunction with the patients' medical records. In order to be enrolled in this study, patients had to have at least one 0.6Á2.0-cm hypervascular lesion in AP during the dynamic MR imaging. The lesion had to be verified histologically or by serial follow-up imaging studies without any technical failure from serious motion artifacts. To avoid unpredictable signal variations related to intra-or extralesional lipid contents, inphase and opposed-phase images were interpreted together for pre-and postcontrast images (7) . In addition to the four histologically confirmed HCCs, 65 additional lesions were regarded as hypervascular HCCs by a combination of clinical and radiologic criteria, including increased tumor marker levels, interval tumor growth within 1 year accompanied by hypervascular tumor staining on hepatic arteriography, and sustaining nodular accumulation of iodized oil after transarterial chemoembolization.
The study population consisted of 53 patients (39 men and 14 women), ranging in age from 39 to 78 years (mean 57 years), who had at least one small hypervascular HCC in a cirrhotic liver. Hepatic cirrhosis was verified by a gun-needle biopsy (n0 10) or clinical course including serial laboratory findings and imaging features (n043). The predominant cause of cirrhosis was hepatitis B (n 049; including four patients with concomitant hepatitis C); a limited number of cases were also caused by hepatitis C (n 02) or ethanol abuse (n02).
To evaluate PP and DP imaging features for use in distinguishing HCCs from benign hypervascular lesions, we chose a comparative lesion group by reviewing the initial MR imaging and follow-up imaging studies of the other 0.6Á2.0-cm small hypervascular lesions which did not show any imaging or histological evidence of HCC. In the comparative group, we included lesions that had disappeared or decreased in size during the serial follow-up imaging studies or those that had not changed during the more than 2 years of follow-up imaging studies. However, we excluded lesions that showed water-like T2W hyperintensity and sustained contrast enhancement on delayed-phase imaging compatible with typical hemangiomas (n03). In addition, to reduce selection bias in the future analysis of the imaging features, we also excluded subcapsular wedge-shaped hypervascular lesions on AP that were not distinguished from the background parenchyma on any other imaging sequences (n 033), which is suggestive of typical pseudolesions (4) . Finally, a total of 74 benign lesions determined by long-term imaging follow-up (from 24 months to 60 months, mean 38.6 months) were included in the comparative group, and all of the 143 small hypervascular lesions including HCC and benign lesions were marked by electronic arrows and saved on the AP images. The signal intensity of the demarcated lesions compared to the background parenchyma on precontrast T1W and T2W images was also determined and recorded by the same reviewer.
Data analysis
For the 143 demarcated lesions (HCCs, n069; benign lesions, n074) on the AP images, the corresponding PP and DP images from threephased dynamic MR imaging were independently evaluated by two observers who had 1 and 4 years of experience of hepatic MR imaging, respectively. These observers were blinded in regard to the precontrast T1W and T2W imaging features and the final diagnosis of each lesion. The signal intensities of the lesions were subjectively assigned to a category (hypo-, iso-, or hyperintense) related to the background hepatic parenchyma. The appearance of peripheral or perilesional rim enhancement (absent, present) was also determined for each lesion. Interobserver variability was calculated using the k statistic (marginal, 0.01Á0.20; fair, 0.21Á0.40; moderate, 0.41Á0.60; good, 0.61Á0.80; excellent, 0.81Á1.00). A chi-square test was performed to evaluate the difference between the subjective findings for HCCs and benign lesions from each observer. The longest dimension of each demarcated lesion on a magnified view of the AP images was independently measured with electronic calipers on the PACS monitor by the same observers, and the mean value of two separate measurements was used for data description and subsequent analysis.
The sensitivity, specificity, and positive and negative predictive values (PPV, NPV) for the diagnosis of HCC were calculated for the hypointensity on PP and DP images and the presence of peripheral rim enhancement. For each calculation, the summated data for the observations from the two different observers were used to get the mean values relative to the size of the lesions (6Á10 mm, 11Á15 mm, 16Á20 mm). According to the signal intensity characteristics for precontrast T1W and T2W images, we separately calculated the sensitivity, specificity, PPV, and NPV in the diagnosis of HCC using the same parameters for the PP and DP images. For all statistical evaluations, a P value less than 0.05 indicated a statistically significant difference.
Results
The interobserver agreement was excellent in evaluating DP images (k00.833) and good in evaluating the PP images (k00.777). The agreement was also good in determining the presence of rim enhancement (k00.742). Due to the relatively larger number of iso-or hyperintense lesions, PP did not provide a statistically significant ability to differentiate between HCCs and benign lesions (P 0.05 for both observers). With DP, there was a markedly increased number of hypointense HCCs (43% for both observers) that were significantly different than benign lesions (PB0.001 for both observers) (Figs. 1Á3, Table 1 ). The prevalence of rim enhancement was significantly higher in HCCs (observer 1, 27.5%; observer 2, 29%; P B0.001 for both observers) than in benign conditions (B3% for both observers) ( Figs. 2 and 4 ). With the exception of four HCCs (two HCCs on PP and DP simultaneously, and two HCCs on PP only), rim enhancements were only identified by each observer on DP images. Table 2 contains a summary of the lesion sizes, sensitivity, specificity, PPV, and NPV from the three MR imaging features (PP hypointensity, DP hypointensity, and rim enhancement) in the diagnosis of HCCs. The overall sensitivity of the hypointensity suggesting contrast washout on PP and DP images, and rim enhancement was 19.6%, 43.5%, and 28.3%, respectively, whereas the specificities of the three MR imaging features were much higher (85%, regardless of lesion size) ( Table 2 ). Among the PPVs from different imaging features and size ranges, the PPV of DP hypointensity ranging from 6 to 10 mm showed the lowest value (60%) ( Table 2 ). After the exclusion of the lesions showing precontrast T1W hypointensity (HCCs, n032; benign lesions, n04) or T2W hyperintensity (HCCs, n039; benign lesions, n09), which are well-known findings of overt HCCs on MR imaging (3), the overall sensitivities and PPVs of each imaging feature were markedly decreased ( Table 3 ).
Discussion
As with CT, the standard multiphasic dynamic MR imaging protocol consists of AP, PP, and DP imaging, and the ''washout'' of the contrast agent, seen as a hypointense appearance after AP, can be used to characterize the HCCs (8Á10). In comparison to CT, where the volume of contrast material is larger and the injection duration longer, MR imaging has a short injection duration of contrast material with a narrower time window for AP imaging. Like real-time ultrasonography, using a smaller volume (B5 ml) of second-generation IV contrast agent (11, 12) , we presumed that there could be a higher chance of demonstrating early washout of the arterially induced intralesional contrast material on MR imaging compared to CT. In our study, the specificity of the hypointense washout appearance with PP was highly specific (97%) for the diagnosis of HCC (Fig. 2) ; however, the sensitivity was not sufficient (20%) to be a reliable imaging feature for the diagnoses of small hypervascular HCCs. Moreover, the prevalence of hyperintensity on PP for HCCs was higher than that of pseudo-or benign lesions ( Fig. 3 , Table 1 ). Most of the patients in the present study had advanced macronodular cirrhosis from chronic B viral hepatitis with pronounced structural distortion. Regarding the reason for the low prevalence of washout appearance, we speculate that the insufficiency of contrast-enhanced portal venous flow during PP in our patients might result in delay in the timing of the optimal lesion-to-liver contrast difference, making it difficult to meet the typical washout appearance of arterial hypervascular lesions on PP images. In a recent study of contrast-enhanced ultrasonography by FAN et al, most of the moderately or poorly differentiated hypervascular HCCs showed washout appearance during PP, whereas well-differentiated HCCs or clear-cell carcinomas showed rather subtle and delayed washout (11) . According to the small size of the subjected lesions, there is another possibility that many of the HCCs were well-differentiated hypervascular lesions showing low prevalence of washout on PP in our study.
Aside from the ability of DP to detect small, rather well-differentiated hypovascular HCCs on dynamic CT (13Á15), MARRERO et al. (8) reported that the DP hypointensity of an arterially hypervascular lesion is the strongest independent predictor of HCC on dynamic MR imaging, regardless of the lesion size. Various mechanisms have been postulated to explain the DP hypointensity of HCCs. First, the fibrotic background parenchyma of Acta Radiol 2008 (7) advanced cirrhosis retains contrast material and appears hyperintense on DP, which distinguishes it from the non-fibrotic small HCCs. The volume of the intercellular space of HCCs is smaller than that of the wider sinusoidal space of background parenchyma. Also, the non-tumorous parenchyma contains a larger amount of the contrast material that is not fully excreted from the circulation in the DP, which is thought to play a role in this difference (16) . It is also possible that the inherent signal intensity influences the signal intensity on DP for T1W hypointense lesions on the precontrast images. In the present study, we examined 52-cm small lesions and found that the overall sensitivity of DP hypointensity was only 43% and depended on the subdivided lesion size ( Table 2 ). In the subcentimeter lesions, the PPV for the diagnosis of HCC by DP hypointensity also had a limited value (60%), even though the specificity was much higher (89%) due to the prevalence of subcentimeter benign lesions. In the MARRERO et al. study (8) , the sensitivity of DP hypointensity was 80% (4/5 HCCs); the number of all 52-cm lesions was very limited (n026), making it difficult to directly compare their results with ours. In the present study, we realized that even though DP hypointensity was more sensitive than PP hypointensity, the diagnostic value of both imaging features was not so promising. The limited PPV of DP hypointensity in the subcentimeter HCCs seemed to be related to a number of false-positive lesions. These false positives originated from the parenchymal distortion of advanced cirrhosis, consisting of reticular fibrosis and macronodular regeneration, resulting in pseudo-washout appearance surrounded by fibrotic reticulations for the benign conditions ( Fig. 4) . Another possibility is that a small portion of the false-positive lesions from DP hypointensity were related to the unusual hypervascular dysplastic or regenerative nodules spontaneously regressed or unchanged during the long-term follow-up (8, 17) .
Compared to CT, besides the previously mentioned difference in the concentration and injection duration of the IV contrast material, gadopentetate dimeglumine is a purely extracellular agent that is not absorbed in the hepatocytes and cannot increase the cellular signal intensity in the background liver (18, 19) . Like the purely intravascular microbubble contrast material-enhanced ultrasonography showing the isoechoic appearance of hypervascular HCCs on DP (12), we presumed that this phenomenon could potentially decrease the incidence of DP hypointensity on MR imaging; however, we had no corresponding CT data, and the degree of hepatocellular absorption of iodinated contrast material on 5-min-delayed CT was beyond the scope of the present study.
Fibrous encapsulation is also one of the typical findings of HCCs (20, 21) , which is indicative of expansile tumor growth and is well demonstrated in 1.5-cm or larger HCCs (22) . IANNACCONE et al. (13) reported that 25 of 250 HCCs (10%) had a capsule detected only on DP images of dynamic CT, regardless of the tumor size. In the present study, even though the sensitivities depended on the lesion size (Table 2) , the prevalence of rim enhancement was higher than in the previous report (13) . Also, the PPV and specificity were excellent, with the exception of a few benign cases that could not be differentiated from hepatic fibrosis around the regenerating nodules or other benign lesions. In some of the cases in this study, the peripheral or perilesional coronal enhancement mimics capsular enhancement in PP, due to washout of the contrast material from the center of the lesion (23, 24) , and contributes to the increased incidence of rim enhancement (Fig. 2) .
While the values for precontrast T1W hypointensity and T2W hyperintensity are limited with advanced cirrhotic liver (25) , the values are (Table 3 ). This study had several limitations. Due to its retrospective nature, histologic specimens were not available for most of the lesions. Gun-needle biopsy of hypervascular lesions is not practical and is typically reserved for gradually enlarged lesions without definite evidence of hypervascular features on imaging follow-up studies. According to the recently modified criteria for the noninvasive diagnosis of HCCs of the European Association for Study of the Liver (5, 10), which are reinforced by the iodized-oil CT findings in the present study, we believe that it is unlikely that rare hypervascular benign hepatocellular lesions could seriously alter the results in the present study. Secondly, due to the arbitrary exclusion of typical hemangiomas and subcapsular pseudolesions, our sensitivity, specificity, PPV, or NPV could not be adjusted for general populations. Despite the potential bias in patient selection, we tried to exclude easily defined benign lesions to investigate the practical value of PP and DP for difficult cases of lesion characterization.
Finally, due to the high prevalence of hepatitis B cirrhosis in this study, our results should be complemented by further research dealing with alcoholic or hepatitis C cirrhosis that are more prevalent in Western countries.
In conclusion, although 5-min DP provides better sensitivity than PP, both PP and DP show a limited value in the diagnosis of small hypervascular HCCs, depending on the size of the lesion. In this study, the deteriorated differential value of PP and DP for small HCCs without T1W hypointensity or T2W hyperintensity versus benign hypervascular lesions highlights the importance of a combined review using precontrast imaging data for accurate diagnosis of small hypervascular HCCs in cirrhotic liver.
